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Abstract
Background: Silicosis is an occupational lung disease caused by inhalation of silica dust characterized by lung inflammation
and fibrosis. Previous study showed that Th1 and Th2 cytokines are involved in silicosis, but Th1/Th2 polarization during the
development of silicosis is still a matter of debate. Regulatory T cells (Treg cells) represent a crucial role in modulation of
immune homeostasis by regulating Th1/Th2 polarization, but their possible implication in silicosis remains to be explored.
Methodology/Principal Findings: To evaluate the implication of Treg cells in the development of silicosis, we generated the
Treg-depleted mice model by administration of anti-CD25 mAbs and mice were exposed to silica by intratracheal instillation
to establish experimental model of silica-induced lung fibrosis. The pathologic examinations show that the Treg-depleted
mice are susceptive to severer inflammation in the early stage, with enhanced infiltration of inflammatory cells. Also,
depletion of Treg cells causes a delay of the progress of silica-induced lung fibrosis in mice model. Further study of mRNA
expression of cytokines reveals that depletion of Tregs leads to the increased production of Th1-cytokines and decreased
production of Th2-cytokine. The Flow Cytometry and realtime PCR study show that Treg cells exert the modulation function
both directly by expressing CTLA-4 at the inflammatory stage, and indirectly by secreting increasing amount of IL-10 and
TGF-b during the fibrotic stage in silica-induced lung fibrosis.
Conclusion/Significance: Our study suggests that depletion of Tregs may attenuate the progress of silica-induced lung
fibrosis and enhance Th1 response and decelerate Th1/Th2 balance toward a Th2 phenotype in silica-induced lung fibrosis.
The regulatory function of Treg cells may depend on direct mechanism and indirect mechanism during the inflammatory
stage of silicosis.
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Introduction
Silicosis is characterized by lung inflammation and fibrosis [1,2],
which is caused by inhalation of silica particle, an oxide of silicon
with a chemical formula of SiO2. Silicotic nodules are known as
the major pathological character of silicosis. Silicosis has been
studied extensively, yet little is known about the crucial cellular
and molecular mechanisms that initiate and propagate the process
of inflammation and scarring. Several evidences support that the
pathogenesis of silicosis involves uncontrolled immune processes
[3]. Alveolar macrophages, neutrophils, dendritic cells and many
inflammatory mediators such as cytokines and chemokines are
identified involved in the development of silicosis. Macrophages
can be activated by silica particles, followed by the activation of
the apoptosis associated speck-like protein- and NALP3-dependent
inflammasome, which may trigger the production of IL-1b [4–6].
Upon silica particles stimulation, T lymphocytes were activated by
antigen presenting cells (APC) such as dendritic cells (DC) and
macrophages in the processing and presentation of silica antigen.
Participation of CD4+ T cells, including Th1 and Th2 cells, in the
pathogenesis of lung fibrosis induced by silica particles has been
indicated in several studies [7–9]. Adaptive Th1/Th2 polarization
during the development of silicosis is still a matter of debate. The
role of Th1 immune response in silicosis has not been conclusively
defined. Some studies showed that Th1 immune responses were
dominant in the inflammatory stage of silicosis; however,
contradictory findings on the functions of IFN-c in silica-induced
lung fibrosis have been reported [10–12]. There are several
evidences supporting that silica-induced lung fibrosis is correlated
with markers of a Th2-like response such as increased IL-4 levels
[12–14]. IL-4-/- and IL-4Ra-/- mice did not, however, appear
protected against the development of silicosis, suggesting that Th2
immune response is not essential for the development of this
fibrotic disease [15]. Several evidences support that the patho-
genesis of silicosis involves uncontrolled immune processes [3].
This may suggest that a more complex immunological mechanism,
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development of silicosis. As a result, the cells, which modulated the
immune homeostasis, appear to be significant for the development
of silicosis.
Regulatory T cells (Treg cells) represent a crucial role in the
maintenance of immune homeostasis in the airways. Naturally
occurring CD4+CD25+ regulatory T cells regulate immune
responses against external antigens via suppression of CD4+ and
CD8+ T cells [16–19]. Major populations of regulatory T cells
studied in the context of lung diseases are natural thymic-derived
CD4+CD25+Foxp3+ Treg cells and peripherally antigen-induced
CD4+ Treg cells, which comprise both Foxp3-positive and –
negative populations [20,21]. The mechanisms by which Treg
cells inhibit the function of immune cells have been described [22].
A major inhibitory mechanism appears to be via anti-inflamma-
tory cytokines such as IL-10 and TGF-b [23,24], but inhibitory
molecules such as CTLA-4 are also likely to contribute [22]. The
suppression of Th1-mediated diseases by CD4+CD25+ Treg cells
has been well documented [25,26]. Human studies suggest that
CD4+CD25+ Treg cells also suppress Th2-type diseases [27–29];
mouse studies have yielded contradictory results [30–34]. The
percentage of peripheral blood CD4+CD25+ Foxp3+ Treg cells is
slightly lower in silicosis patients (SILs) compared with healthy
donors (HD) and the function of Treg cells in SILs is less
significant than in HDs [35]. Treg cells are identified in the
development of silicosis; however, the mechanism of
CD4+CD25+Foxp3+ Treg cells to regulate immune homeostasis
is still poorly understood in silicosis.
The objective of this study was 1) to investigate the role of Treg
cells during inflammation and fibrosis in silicosis, 2) to study
whether Treg cells regulate the process of silicosis by modulating
the maintenance of immune homeostasis in the lung. We used
anti-CD25 antibodies to neutralize regulatory T cells and assessed
the immune responses of silica-induced lung fibrosis. We
demonstrate that the depletion of Treg cells exacerbated the early
lung inflammation and delayed the process of fibrosis and Th1/
Th2 balance toward a Th2 dominant response in experimental
model of silicosis.
Results
Enhancement of early lung inflammation in silica-
induced lung fibrosis in mice by depletion of
CD4+CD25+ regulatory T cells
To test the potential suppression of silica-induced lung fibrosis
in mice by endogenous CD4+CD25+ Treg cells, we generated
CD25+ T cell-depleted C57BL/6 mice by injection of the anti-
CD25 mAb PC61. We examined lung responses to silica in mice
injected with saline, silica and silica + anti-CD25 mAb at day 7, 28
and 56. To check the efficiency of neutralizing anti-CD25 mAb,
we assessed the percentage of CD4+CD25+ regulatory T cells in
the spleen. According to Fig. 1A and B, injection of anti-CD25
mAb successfully depletes CD4+CD25+ regulatory T cells
continuously even at day 56. The percentage of CD4+CD25+
fraction in silica-treated mice increased compared with saline-
treated mice at day 7 (Fig. 1B). This fraction gradually reduced for
chronic lung immune response induced by silica (Fig. 1).
Early lung inflammation was significantly increased in silica-
treated and Treg-depleted mice compared with saline-treated
control animals, as measured at day 7, 28 and 56 by inflammatory
cell counts in BALF (Fig. 2). We examined total cells, neutrophils,
macrophages and lymphocytes in BALF. At day 7, more
inflammatory cells were infiltrated in silica-treated and Treg-
depleted mice (Fig. 2A). Treg cell ablation demonstrated
significant reduction of total cells at day 28 and 56 compared
with those at day 7 (Fig. 2A). Treg-depleted mice dramatically
enhanced neutrophil accumulation (Fig. 2B). The neutrophil
accumulation declined gradually in both silica-treated and Treg-
depleted mice at day 28 and 56 (Fig. 2B). This suggested that Treg
cells contributed to limit the severely acute neutrophil accumula-
tions during the early lung inflammation. For chronic inflamma-
tory responses, neutrophil accumulations were significantly limited
in both silica- and Treg-treated mice at day 28 and 56 (Fig. 2B).
The number of macrophages reduced clearly in Treg-depleted
mice compared with silica-treated mice at day 28 (Fig. 2C). In
silica-treated mice, the number of macrophages reached peak at
day 28 and reduced at day 56 (Fig. 2C). At day 28, there was
Figure 1. Injection of anti-CD25 mAb sufficiently depletes CD4
+CD25
+ regulatory T cells in vivo continuously. (A) C57BL/6 mice were
treated i.p. with 100 mg anti-CD25 mAb or control IgG, the percentage of CD4
+CD25
+ Treg cells in the spleen was assayed by using anti-CD4 and
CD25 mAb by flow cytometry. (n=5) (B) Percentage of CD4
+ T cells expressing CD25 was shown in the graph. (n=5) (*, as compare with the saline
control group, P,0.05; g, as compare with the silica group, P,0.05).
doi:10.1371/journal.pone.0015404.g001
Tregs Depletion Attenuates Lung Fibrosis
PLoS ONE | www.plosone.org 2 November 2010 | Volume 5 | Issue 11 | e15404clearly reduced number of lymphocytes in Treg-depleted mice
compared with silica-treated group (Fig. 2D).
Depletion of CD4+CD25+ regulatory T cells decelerated
the progress of silica-induced lung fibrosis in mice model
To investigate the role of CD4+CD25+ regulatory T cells in the
pathogenesis of silica-induced lung fibrosis, the lung tissues of mice
were observed by light microscope to monitor pathological
changes and graded for silicotic nodule (Table 1). No obvious
abnormalities were observed in the lungs of mice that received
normal saline at day 7, 28 and 56 (Fig. 3a1, b1 and c1). In silica-
treated group, there was a large infiltration of inflammatory cells
and alveolar septal thickening in the lungs, and irregular cellular
nodules were observed, at day 7 after silica instillation (Fig. 3a2).
However, at day 7 in Treg-depleted group, significantly severer
infiltration of inflammatory cells and alveolar septal thickening in
the lungs, and more irregular cellular nodules were observed
compared with that in silica-treated group (Fig.3a3). At day 28, the
inflammation in the lungs of silica-treated mice was significantly
extenuated. There were more and larger cellular nodules
compared with day 7. Fibrotic cellular nodules were observed
(Fig. 3b2). While in Treg-depleted group at day 28, inflammation
was extenuated and there were a bit larger cellular nodules but
reduced number of cells in the nodules (Fig. 3b3). At day 56,
fibrotic cellular nodules increased and cellular fibrotic nodules
appeared in silica-treated group (Fig. 3c2). In Treg-depleted
Figure 2. Depletion of Treg cells increases the accumulation of inflammation cells in lung response to silica. The total cells (A),
neutrophils (B), macrophages (C) and lymphocytes (D) in BALF were counted by using Giemsa staining. (*, as compare with the saline control group,
P,0.05; g, as compare with the silica group, P,0.05; #, as compare with 7day of the same group, P,0.05; &, as compare with 28day of the same
group, P,0.05).
doi:10.1371/journal.pone.0015404.g002
Table 1. Silicotic nodule of the mice lungs in each group at day 7, 28 and 56.
Groups 7 day after instillation 28 day after instillation 56 day after instillation
n silicotic nodule grade n silicotic nodule grade n silicotic nodule grade
saline control 5 0 5 0 5 0
silica 5 I 5 I+,II 5 II+,III
Silica+anti-CD25mAb 5 I 5 I,I+ 5I ,II
doi:10.1371/journal.pone.0015404.t001
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and fibrotic cellular nodules at day 56 were observed (Fig. 3c3).
According to the pathologic examination, depletion of Treg cells
caused delay of the progress of silicosis but did not change the
consequence (Table 1 and Fig. 3).
Depletion of CD4+CD25+Foxp3+ regulatory T cells
enhanced Th1 response and decelerated Th1/Th2
balance toward a Th2 phenotype in mice model of
silica-induced lung fibrosis
Foxp3 expressed in peripheral CD4+CD25+ T cells and played
an important role in the development and function of
CD4+CD25+ Treg cells. To investigate the role of
CD4+CD25+Foxp3+ regulatory T cells in silica-induced lung
fibrosis, we first assessed the population of CD4+CD25+Foxp3+ T
cells in HLN, spleen and BALF. The injection of anti-CD25 Abs
neutralized most of the CD4+CD25+Foxp3+ fraction and these
were consistent with the depletion of CD4+CD25+ T cells (Fig. 4).
At day 7, the population of CD4+CD25+Foxp3+ T cells in HLN
increased significantly in silica-treated mice compared with
saline-treated control mice (Fig. 4A and B). In spleen,
CD4+CD25+Foxp3+ T cells increased significantly in silica-
treated mice compared with saline-treated control group at day
7 (Fig. 4C and D). This fraction reduced gradually at day 28 and
56 in silica-treated group (Fig. 4C and D). The percentage of
CD4+CD25+Foxp3+ T cells in silica-treated mice also increased
clearly in BALF compared with saline control mice at day 7, 28
and 56 (Fig. 4E and F). CD4+CD25+Foxp3+ T cells reached peak
at day 28 and reduced at day 56 in silica-treated group, but were
still significantly higher than those at day 7 (Fig. 4E and F).
The confocal immunofluorescence assay showed that the
CD4+Foxp3+ T cells were identified in the lung tissue sections.
The CD4+Foxp3+ T cells were observed in and around the cellular
nodules, and the amount of the CD4+Foxp3+ T cells in silica-
treated group is slightly more than that in Treg-depleted group at
day7 (Fig.S1a2 and Fig.S1a3).Atday28and56, the amount ofthe
CD4+Foxp3+ T cellsinboth silica-treatedandTreg-depleted group
reduced obviously, and the most of the CD4+Foxp3+ T cells were
around the nodules and little was in the nodules (Fig. S1).
Next we want to investigate the regulatory role of Treg cells in
silica-induced lung fibrosis in mice. We extracted total RNA from
lung homogenates and applied samples for realtime RT-PCR.
Typical Th1 (IL-2, IFN-c) and Th2 (IL-4) cytokines were studied.
At day 7, both silica-treated and Treg-depleted group showed
higher level of IL-2 expression compared with saline control group
(Fig. 5A). The level of IL-2 in silica-treated group reduced to the
same level with saline control group at day 28 and 56 (Fig. 5A). In
Treg-depleted group, the level of IL-2 was still significantly higher
than those in the other two groups at day 28 and 56 (Fig. 5A). In
silica-treated group, the level of IL-2 increased clearly at the early
inflammatory stage of silicosis (day 7) and decreased during the
fibrotic reaction of silicosis (day 28 and 56). The level of IFN-c in
Treg-depleted group was significantly higher than that of silica-
treated group at day 7, 28 and 56, and in both Treg-depleted and
silica-treated group, the expression of IFN-c was more than the
saline group (Fig. S2). Depletion of CD4+CD25+Foxp3+ regula-
tory T cells enhanced Th1 response at the later stage of lung
fibrosis. These data suggested that CD4+CD25+Foxp3+ regula-
tory T cells could suppress Th1 response during the early
inflammation period of silica-induced lung injury.
The level of IL-4 increased gradually during the process of
silicosis and reached peak at day 56 in silica-treated group (Fig. 5B).
These data were consistent with previous. At day 56, the level of IL-
4 in Treg-depleted group was higher than that in saline control
group butlowerthan that insilica-treated group(Fig.5B).Depletion
of CD4+CD25+Foxp3+ regulatory T cells limited and delayed the
Figure 3. Histopathology changes in mouse lungs after instillation with HE staining (x200). a1-a3, day 7; b1-b3, day 28 and c1-c3, day 56.
a1-c1, saline group; a2-c2, silica group; a3-c3,silica+anti-CD25mAb.
doi:10.1371/journal.pone.0015404.g003
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CD4+CD25+Foxp3+ regulatory T cells played a regulatory role in
silica-induced lung fibrosis by modulating Th1/Th2 balance.
The regulatory function of CD4+CD25+ Foxp3+
regulatory T cells in silica- induced lung fibrosis in mice
depends on both direct and indirect mechanism
We next sought about the mechanisms of CD4+CD25+Foxp3+
regulatory T cells in silica-induced lung fibrosis. First, we checked
the expression of CTLA-4 in HLN and spleen. The expression of
CTLA-4 in Treg-depleted mice reduced clearly and was consistent
with the depletion of CD4+CD25+ T cells (Fig. 6). In silica-treated
mice, the number of Treg cells expressing CTLA-4 increased
significantly at day 7 compared with saline control mice in both
HLN and spleen (Fig. 6). In HLN, the numbers of Treg cells
expressing CTLA-4 in silica-treated mice declined to the similar
level of those in saline control mice at day 28 (Fig. 6A and B). At
day 56, the numbers of Treg cells expressing CTLA-4 in silica-
treated mice were less than those in saline control mice in HLN
(Fig. 6A and B). The silica-treated mice still showed more Treg
cells expressing CTLA-4 compared with saline control mice in
spleen at day 28 while no difference at day 56 (Fig. 6C and D).
To investigate the regulatory role of Treg cells in silica-induced
lung fibrosis of mice mould, we next explored whether Treg cells
regulated the immune homeostasis through IL-10 and/or TGF-b
during the short- and long-term lung responses to silica particles.
At day 7, 28 and 56, we found a significantly increased lung
expression of IL-10 and TGF-b mRNA in lung homogenates from
silica-treated mice compared with saline controls (Fig. 7A and B).
Depletion of Treg cells caused significantly reduction of IL-10
expression compared with silica-treated mice (Fig. 7A). The
expression of TGF-b in Treg-depleted mice kept in a similar level
at day 7, 28 and 56 (Fig. 7B). At day 28, expression of TGF-b
mRNA in silica-treated and Treg-depleted mice was significantly
higher than that in saline controls (Fig. 7B).
Discussion
Silicosis, an occupational lung disease, is caused by inhalation of
crystalline silica dust. The pathogenesis of silicosis involves alveolar
cell injury and activation followed by cytokine signaling and cell
recruitment in the areas of silica dust deposition [1,2]. In this
study, we demonstrated that Treg cells regulated immune
responses against silica particles via suppression of inflammatory
cells in the early stage. Treg cells may modulate Th1/Th2 balance
toward a Th2 dominant response by suppressing Th1 response in
experimental model of silica-induced lung fibrosis. Depletion of
Treg cells decelerated the progress of abnormal repair and fibrosis
against silica particles.
In this study, first we generated CD25+ T cell-depleted C57BL/6
mice by injection of the anti-CD25 mAb PC61 and examined lung
responses to silica in mice. CD4+CD25+Treg cells were depleted
continuously by injection of anti-CD25 mAb (PC61). Since the
recently activated effector T cells may also express CD25
transiently, it is difficult to exclude the possibility that the mAb
related to depletion of activated T cells. Despite that the anti-CD25
mAb used in our study has also been used in other studies to
transiently deplete Treg cells [36,37]. There is also a study showed
that the anti-CD25 mAb selectively depleted cells with highest level
of CD25 expression, and the changed intensity of immune response
was more consistent with the depletion of Treg cells than that of
effector T cells [37]. In our study, the percentage of CD4+CD25+
Treg cells increased at early stage and gradually reduced later in
silica-treated group. This suggested that naturally occurred Treg
cells played some roles in silica-induced lung fibrosis. We then
examinedlung responsestosilica bycountingtheinflammatorycells
in BALF of mice injected with saline, silica and silica + anti-CD25
mAb at day 7, 28 and 56. Depletion of CD4+CD25+ Treg cells
demonstrated drastic enhancement of early lung inflammation,
especially accumulation of neutrophils. Lung neutrophils have an
importantroleintheearlystageofinflammationinresponsetosilica
particles. Our results suggested that Treg cells contributed to limit
Figure 5. Treg cells affect the Th1/Th2 balance in the mice model of silica-induced lung fibrosis. Typical Th1 (IL-2) (A) and Th2 (IL-4)(B)
cytokines were assayed by realtime RT-PCR by using -ggCt method. (n=5) (*, as compare with the saline control group, P,0.05; g, as compare with
the silica group, P,0.05; #, as compare with 7day of the same group, P,0.05).
doi:10.1371/journal.pone.0015404.g005
Figure 4. CD4+CD25+FOXP3+ T cells were the functional fraction of Treg cells in the silica-induced lung fibrosis. Treg cells in HLN (A),
spleen (C) and BALF (E) were calculated by flow cytometry. (n=5) The percentage of CD4+ T cells expressing CD25 and FOXP3 was shown in the
graph (B, HLN; D, spleen; F, BALF) (n=5) (*, as compare with the saline control group, P,0.05; g, as compare with the silica group, P,0.05; #,a s
compare with 7day of the same group, P,0.05; &, as compare with 28day of the same group, P,0.05).
doi:10.1371/journal.pone.0015404.g004
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PLoS ONE | www.plosone.org 6 November 2010 | Volume 5 | Issue 11 | e15404Figure 6. The expression of CTLA-4 in Treg cells in the HLN and spleen. CTLA4 expressed in CD4+CD25+FOXP3+ Treg cells of HLN (A) and
spleen (C) was assayed by flow cytometry. (n=5) The number of Treg cells expressing CTLA4 of HLN (B) and spleen (D) was shown in the graph.
(n=5) (*, as compare with the saline control group, P,0.05; g, as compare with the silica group, P,0.05; #, as compare with 7day of the same
group, P,0.05; &, as compare with 28day of the same group, P,0.05).
doi:10.1371/journal.pone.0015404.g006
Figure 7. The function of Treg cells depends on both IL-10 (A) and TGF-b (B). The IL-10 and TGF-b mRNA were assayed by realtime RT-PCR
by using -ggCt method. (n=5) (*, as compare with the saline control group, P,0.05; g, as compare with the silica group, P,0.05; #, as compare
with 7day of the same group, P,0.05; &, as compare with 28day of the same group, P,0.05).
doi:10.1371/journal.pone.0015404.g007
Tregs Depletion Attenuates Lung Fibrosis
PLoS ONE | www.plosone.org 7 November 2010 | Volume 5 | Issue 11 | e15404the severely acute accumulation of inflammatory cells especially
neutrophils in the early stage to silica.
Next we examined the pathology of lung tissues. Silicotic
nodules were graded as follows: cellular nodules as Stage I; fibrotic
cellular nodules as Stage II; cellular fibrotic nodules as Stage III;
fibrotic nodules as Stage IV. At the early stage, the infiltration of
inflammatory cells was observed in silica group. However,
significantly severer infiltration of inflammatory cells, alveolar
septal thickening and more irregular cellular nodules were
observed in Treg-depleted group. The severer infiltration of
inflammatory cells was consistent with the enhancement of
inflammatory cell by counting. Later after challenged by silica,
the silicotic nodule grade was a little higher in silica group than in
Treg-depleted group. In silica group, fibrotic cellular nodules
increased and cellular fibrotic nodules even appeared. However,
only a small amount of irregular cellular nodules and fibrotic
cellular nodules could be observed occasionally in Treg-depleted
group. Depletion of Treg cells actually delayed the progress of lung
fibrosis, but did not prevent the consequence of silica-induced lung
fibrosis. This result provided a new insight to slow down the
development of silicosis by using anti-CD25 antibody.
To determine the mechanism of Treg cells in silica-induced
lung fibrosis, we first examined the effective fraction (CD4+
CD25+Foxp3+ Treg cells) in HLN, spleen and BALF. Most of the
CD4+CD25+Foxp3+ fraction were neutralized and these results
were consistent with that the anti-CD25 mAb selectively depleted
those cells expressing the highest levels of CD25, a population
recently demonstrated to comprise primarily Foxp3+ cells [38,39].
At early stage (day 7), the CD4+CD25+Foxp3+ T cells in HLN
and spleen of silica group increased significantly. This fraction
in silica group reduced gradually at the later stage (day 28 and 56).
The location of the CD4+Foxp3+ Treg cells in lung tissue slices
was in and around the cellular nodules at early inflammatory
stage, but around the cellular nodules at the late fibrosis
stage.
And the amount of the CD4+Foxp3+ Treg cells reduced at the late
stage, which was consistent with the results of the depletion Treg
cells. These results suggested that CD4+CD25+Foxp3+ Treg cells
were the mainly effective fraction in response to silica particles.
Secondly, we want to investigate the regulatory role of
CD4+CD25+Foxp3+ Treg cells in silica-induced lung fibrosis by
studying the mRNA expression of typical Th1 (IL-2, IFN-c) and
Th2 (IL-4) cytokines. Both silica group and Treg-depleted group
secreted high level of IL-2 at early stage. The level of IL-2 in silica
group reduced to the same level with saline control group at late
stage, however, in Treg-depleted group, the level of both IL-2 and
IFN-c was still significantly higher than that of silica group, which
suggested depletion of CD4+CD25+Foxp3+ regulatory T cells
caused failure to modulate the Th1/Th2 balance via suppression
of Th1 response at the later stage of lung fibrosis. Besides, in silica-
treated mice, the level of IL-4 increased gradually during the
process of silicosis and reached peak at day 56, which suggested
that Th2 immune response played some role during the fibrotic
process of silicosis. However, the expression of IL-4 in Treg-
depleted group was not increased as obviously as that in silica
group. Some researchers thought that Th2 immune response was
not essential for the development of this fibrotic disease [15]. And
in our study, depletion of CD4+CD25+Foxp3+ regulatory T cells
indeed limited and delayed the Th2 responses in silica-induced
lung fibrosis. In all, our data suggested that CD4+CD25+Foxp3+
regulatory T cells could modulate Th1/Th2 polarization by
suppressing Th1 response during the early lung inflammation, and
played a regulatory role by modulating Th1/Th2 balance toward
a Th2 dominant response.
The mechanisms by which Treg cells inhibit the function of
effector T cells and other immune cells have been described [22].
A major inhibitory mechanism appears to be via anti-inflamma-
tory cytokines such as IL-10 and TGF-b [23,24], but inhibitory
molecules such as CTLA-4 are also likely to contribute [22]. The
suppression of Th1-mediated diseases by CD4+CD25+ Treg cells
has been well documented [25,26]. Human studies suggest that
CD4+CD25+ Treg cells also suppress Th2-type diseases [27–29];
mouse studies have yielded contradictory results [30–34]. In our
study, the CTLA-4 expression of CD4+CD25+Foxp3+ Treg cells
in Treg-depleted mice reduced clearly and was consistent with the
depletion of CD4+CD25+ T cells. In silica-treated mice, the
number of Treg cells expressing CTLA-4 increased significantly at
the early phase and decreased gradually late in both HLN and
spleen. In HLN, the numbers of Treg cells expressing CTLA-4 in
silica-treated mice were even less than those in saline control mice
at day 56. These suggested that during the inflammatory stage of
silicosis, Treg cells suppressed the inflammation and Th1 immune
response directly by expressing CTLA-4 molecule.
Next we explored whether Treg cells regulated the immune
homeostasis through IL-10 and/or TGF-b during the short- and
long-term lung responses to silica particles. A significantly
increased lung expression of IL-10 and TGF-b mRNA in lung
homogenates from silica-treated mice was observed through the
whole process of silica-induced lung fibrosis. And depletion of
Treg cells caused significantly reduction of IL-10 expression, and
the expression of TGF-b kept in a similar level. These results
suggested that Treg cells also modulated the immune response
against silica indirectly by secreting IL-10 and TGF-b. At the early
stage of silicosis, Treg cells mainly inhibited the inflammation by
CTLA-4 molecule. With the development of silicosis, Treg cells
suppress Th1 immune response by secreting increasing amount of
IL-10 and TGF-b. Then Th1/Th2 polarization shift toward a
Th2 dominant immune response.
Altogether, our study showed that depletion of CD4+CD25+
regulatory T cells decelerated the progress of silica-induced lung
fibrosis and this might provide a new insight in limit the process of
fibrosis for silicosis patients by using anti-CD25 Abs. Depletion of
CD4+CD25+Foxp3+ Treg cells enhanced Th1 response and
decelerated Th1/Th2 balance toward a Th2 phenotype in silica-
induced lung fibrosis. These suggested that Treg cells regulated the
inflammation against silica via suppression of inflammatory cells in
the early stage and Treg cells may modulate Th1/Th2
polarization toward a Th2 dominant response by suppressing
Th1 response in experimental model of silica-induced lung
fibrosis. The regulatory function of CD4+CD25+Foxp3+ Treg
cells in silica-induced lung fibrosis depends on direct mechanism at
the inflammatory stage and indirect mechanism during the fibrotic
stage in silica-induced lung fibrosis.
Materials and Methods
Animal
Female C57BL/6 mice were purchased from SLAC Laboratory
animal co.LTD. (Shanghai, CHINA) at 6–8 weeks of age. All
animals were housed in a specific pathogen-free environment and
maintained on standard mouse chow at an environmental
temperature of 2461uC and a 12/12 h light/dark cycles and
water ad libitum. All animal experiments were approved by the
Animal Care and Use Committee at the China Medical University
with a permit number of CMU62043003, which complies with the
National Institute of Health Guide for the Care and Use of
Laboratory Animals.
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Silica was purchased from Sigma (St., Louse, MO, USA). The
content of the freeing SiO2 dust was .99%, and the particle size
of 80% SiO2 dust was between 1 to 5 mm. Silica was grinded in
saline for 3 hours, boiled in 1N HCl, washed, dried, suspended in
sterile saline. Suspensions were sonicated for 10 min before use.
Silica exposure
45 mice were randomly divided into three groups (n=15) as
follows: the silica+anti-CD25mAb group, silica group and the saline
control group. Animals were anesthetized with intraperitoneal
injection of 2% pentobarbital sodium 45 mg/kg body weight. The
trachea was exposed by opening the neck skin and blunt dissection.
A 7-gauge needle was used to insert into the trachea trans-orally.
Mice received either the suspension of 3 mg silica in a total volume
of 100 ml sterile saline or just the sterile physiological saline in same
volume. The site of surgery was sutured and cleaned with penicillin
and the mice were allowed to recover until they were sacrificed.
CD4+CD25+ regulatory T cell depletion
Mice from silica+anti-CD25mAb group or silica group and
saline control group received intraperitoneal injection with 100 mg
of anti-CD25 mAb (PC61) (BioLegend, 11080 Roselle Street, San
Diego, CA 92121) or rat IgG1 (BioLegend, 11080 Roselle Street,
San Diego, CA 92121) in phosphate buffered saline just one day
before the silica exposure. And repeatedly treated i.p. with PC61
100 mg or rat IgG1 of the same volume every 7 days after the silica
exposure for continuing depletion.
Bronchoalveolar lavage and differential cell counts
Mice were sacrificed at 7, 28 or 56 days after challenged by silica
instillation or sterile physiological saline. The lungs were removed
and washed in cold PBS. Bronchoalveolar lavage fluid (BALF) was
obtained by cannulating the trachea, injecting and retrieving 1 ml
aliquots of sterile physiological saline for 3 times. The BALF was
centrifuged at 1500 rpm for 8 min at 4uC. After lysis of RBC, the
BAL cell pellet was washed and resuspended in PBS. The total cell
counts were determined using standard hematologic procedures.
Cytospin of BAL was prepared and stained with the Wright-Giemsa
method. Macrophage, neutrophil or lymphocyteswereidentified on
200 cells using standard morphologic criteria.
Pathological examination
Lung was fixed in 4% paraformaldehyde -PBS. The tissue was
embedded in paraffin, cut in 6 mm-thick sections. The tissue
sections were stained with hematoxylin and eosin (H&E). Silicotic
nodules were graded as follows: cellular nodules as Stage I; fibrotic
cellular nodules as Stage II; cellular fibrotic nodules as Stage III;
fibrotic nodules as Stage IV.
Confocal immunofluorescence assay
Following extensively rinsing with 0.01 M PBS (pH 7.4) for two
times, the slides of lung tissue were blocked with goat serum
(Histostain-Plus Kits, ZSBG-BIO) for 30 min to reduce nonspe-
cific binding, then incubated with a polyclonal RBITC-conjugated
rabbit anti-CD4 antibody 40 mg/ml (Beijing biosynthesis
biothechnology) for 2 h at room temperature. After washing with
PBS for three times, the slides were incubated with a polyclonal
FITC conjugated rabbit anti-Foxp3 antibody 10 mg/ml (Beijing
biosynthesis biothechnology) for 2 h at room temperature. The
localization of CD4+Foxp3+T cells was captured by a confocal
laser scanning microscope (TCS sp2/AOBS,LEICA) and analyzed
with the leica confocal software package.
Purification of hilar lymph nodes and spleen cells
The hilar lymph nodes (HLN) were harvested and dissected by
using needles then digested with 0.25% trypsin for 5 min at 37uC.
3% fetal bovine serum-PBS was used to end the digestion.
Centrifuge it at 1500 rpm for 8 min at 4uC. The HLN cell pellet
was washed and resuspended in PBS. The spleens were removed,
grinded and mechanically dissociated in cold PBS. After lysis of
RBC, spleen cells were washed and resuspended in PBS.
Flow cytometry
Analysis of cell surface marker expression was performed using a
FACSCantoII (BD, Franklin Lakes, NJ USA) system. Briefly, the
cells from BALF, HLN and spleen were resuspended in PBS and
blocked with purified rat anti-mouse CD16/CD32 (BD Pharmin-
gen, San Jose, CA, USA) for 10 min at 4uC. Cells were then
incubated with anti-mouse PerCP-conjugated CD3 (BD Pharmin-
gen, San Jose, CA, USA), anti-mouse PE-Cy7-conjugated CD4 (BD
Pharmingen, San Jose, CA, USA), and anti-mouse APC-conjugated
CD25 (BD Pharmingen, San Jose, CA, USA) for 20 min at 4uCi n
thedark.Aftercellularsurfacestaining,cellswere washedtwicewith
3% FBS-PBS. 1 ml working solution (0.25 ml fixation/permeabi-
lization concentrate and 0.75 ml fixation/permeabilization diluent)
(eBioscience, San Diego, CA 92121,USA))was added to fix and
permeate the cell membrane for 30 min at 4uC in the dark. To label
the nuclear factor Foxp3, cells were incubated with anti-mouse
FITC-conjugated Foxp3 (eBioscience, San Diego, CA 92121, USA)
for 1 h at 4uC in the dark. In addition, cells from NLH and spleen
were incubated with anti-mouse PE -conjugated CTLA-4 (BD
Pharmingen, San Jose, CA, USA) for 1 h at 4uC in the dark. After
then, cells were washed twice with 3% FBS-PBS and re-suspended
in1%paraformaldehyde-PBS.Dead cellsweregated out depending
on forward scattering (FSC) and side scattering (SSC). Cells were
analyzed with Diva software.
RNA extraction and realtime RT-PCR
Total RNA was isolated from lung homogenates using the
TRIZOLH Reagent (Invitrogen, Carlsbad, CA, USA) according to
the manufacturer’s protocol. The RNA concentration and the
ratio of A 260/280 of were determined by UV spectrophotometer.
The primers and the Taqman probes were designed with the
Primer3 (http://frodo.wi.mit.edu/primer3) and the sequences
were blasted (http://www.ncbi.nlm.gov/BLAST/). PrimeScript
RT- PCR kit (DRR061A, Takara, Japan) was used for realtime
RT- PCR. primer sequences were as follows: IL-2, sense 59-
TTGAGTGCCAATTCGATGATGAG-39, antisense 59-TTGA-
GATGATGCTTTGACAGAAGG-39; IFN-c, sense 59- AAGC-
GTCATTG AATCACACCTG -39, antisense 59- TGACCT-
CAAACTTGGCAATACTC -39; IL-4, sense 59-AAAATCA-
CTTGAG AGAGATCATCGG-39, antisense 59-GTTGCTG-
TGAGGACGTTTG G-39;IL-10, sense 59-GGGGCCAGTA-
CAGCCGGGAA-39, anti-sense 59-CTGGCTGAAGG CAGT-
CCGCA-39;TGF-b, sense59-TGTGGAACTCTACCAGAAAT-
ATAGC-39, anti-sense 59-GAAAGCCCTGTATTCCGTCTC-
39; GAPDH, sense59-CAATGTGTCCGTCGTGGAT CT-39,
anti-sense 59-GTCCTCAGTGTAGCCCAAGATG-39. The
probe sequences were as follows: IL-2, 59-(FAM) CCTCA-
GAAAGTCCACCACAGTTGCT (BHQ1)-39; IFN-c,5 9-(FAM)
CTTCTTCAGCAACAGCAAGGCGAA (BHQ1)-39; IL-4, 59-
(FAM) TGGCGTCC CTTCTCCTGTGACCTCG (BHQ1)-39;
IL-10, 59-(FAM) GCACCCACTTCCCAGTCGGCC AGAG-
CC (BHQ1)-39; TGF-b,59-(FAM) TTCAGCCACTGCCGTAC-
fAACTCCAG (BHQ1)-39; GAPDH, 59-(FAM) CGTGCCG-
C CTGGAGAAACCTGCC (BHQ1)-39.
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at each time point was reverse transcribed in a volume of 20 ml
using the following program:37uC for 15 min and 85uC for 5 s.
2 ml of cDNA was used in a 25 ml realtime PCR reaction volume.
The difference of the amplification efficiency between the target
gene and the housekeeping gene was identified by comparing the
slopes of the standard curves. The PCR reactions were run on ABI
7500 (Applied Biosystems) using the following program: 95uC for
30 s, and 40 cycles of 95uC for 5 s and 60uC for 34 s. Analysis was
performed using the 7500 system software (Applied Biosystems).
Statistical analyses
The SPSS 16.0 software was used to conduct statistical analyses.
The differences between values were evaluated through a one-way
analysis of variance (ANOVA) followed by pair-wise comparison
with the Student-Newman-Keuls test. P,0.05 was considered
statistically significant and all values are means 6SEM.
Supporting Information
Figure S1 The localization of CD4+Foxp3+ T cells
in lung tissue examined by immunofluorescence
(x400). The CD4+Foxp3+ T cells were colocalized in the lung
tissue sections by confocal immunofluorescence microscope,
analyzed with the leica confocal software package. a1-a3, day 7;
b1-b3, day 28 and c1-c3, day 56. a1-c1, saline group; a2-c2, silica
group; a3-c3, silica+anti-CD25 mAb.
Found at: doi:10.1371/journal.pone.0015404.s001 (TIF)
Figure S2 Treg cells suppress the Th1 cytokine (IFN-c)
in the mice model of silica-induced lung fibrosis. IFN-c
cytokine was assayed by real-time RT-PCR by using -ggCt
method. (n=5) (*, as compare with the saline control group,
P,0.05; g, as compare with the silica group, P,0.05; #,a s
compare with 7day of the same group, P,0.05).
Found at: doi:10.1371/journal.pone.0015404.s002 (TIF)
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